Skip to content

Feasibility Study Assessing the Treatment of Fibroadenomata With a Circumferential Sonication Treatment With HIFU

High Intensity Focused Ultrasound for the Treatment of Fibroadenomata (HIFU-F)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02139683
Enrollment
50
Registered
2014-05-15
Start date
2014-01-31
Completion date
2016-01-31
Last updated
2018-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Fibroadenoma

Brief summary

The purpose of this study is to assess the treatment of fibroadenomata with a circumferential sonification treatment with HIFU..

Detailed description

Primary endpoint: fibroadenomata size reduction post-treatment on ultrasound imaging.

Interventions

HIFU treatment in patients with fibroadenoma

Sponsors

King's College London
CollaboratorOTHER
Theraclion
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients \>18 years of age * Fibroadenomata diagnosed according to local hospital protocol; ultrasound alone on patients \<25 and ultrasound plus core-biopsy in patients \>25 (Graded B2 or less) * Visible on ultrasound (Graded U2/U3) * Definitive diagnosis of fibroadenomata confirmed by the Breast multi-disciplinary team meeting (MDT).

Exclusion criteria

* Lesion with atypia or suspicion of phyllodes (Graded B3 or greater) * Pregnant or lactating women * History of laser or radiation therapy to the targeted breast

Design outcomes

Primary

MeasureTime frame
Changes in size of fibroadenomata as recorded on ultrasound imagingMonth 1, Month 3, Month 12

Secondary

MeasureTime frameDescription
Adverse EventsMonth 1, Month 3, Month 12
Patient recorded outcomes measuresMonth 1, Month 3, Month 12Patient questionnaires and VAS scales
Mean treatment timeTreatment visit date
Cost-effectiveness12 months

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026